Salix Pharmaceuticals LTD
SEC CIK 1009356 · SLXP · last insider filing 2015-04-03
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Chappell John F | Director · Chairman of the Board | filed 2006 - 2015 |
| Keane William P | Director | filed 2006 - 2015 |
| D Alonzo Thomas | Director · Acting President and CEO | filed 2006 - 2015 |
| Sirgo Mark A | Director | filed 2008 - 2015 |
| Logan Carolyn J | Director · President & CEO | filed 2006 - 2014 |
| Franco Richard A | Director | filed 2006 - 2012 |
| Harral William III | Director | filed 2006 - 2008 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Creech Timothy J | See Remarks | filed 2014 - 2015 |
| Bertrand William C JR | See Remarks | filed 2013 - 2015 |
| Forbes William P | V.P. Research& Devel & CDO | filed 2006 - 2015 |
| Scruggs Rick D | Executive Vice President | filed 2011 - 2015 |
| Derbyshire Adam C | Sr. VP Finance/CFO | filed 2006 - 2014 |
| Reeth Mark D | Gen Counsel&VP Corp Compliance | filed 2007 - 2012 |
| Taylor David N MD | VP - Chief Medical Officer | filed 2006 - 2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.